GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
GSK Reports Positive Results for Nucala in Patients with Nasal Polyps
2020-04-05
True to Analyst Predictions, Amarin’s Shares Crash Following Vascepa Patent Invalidation
2020-03-31
Green Cross Cell Seeks FDA approval for CAR-T therapy against pancreatic cancer
2020-03-27
Japan Approves World’s First Therapy for Metastatic Non–Small Cell Lung Cancer with METex14
2020-03-26
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
Gilead’s Antiviral Drug, Epclusa gets FDA Nod for Pediatric Hepatitis C
2020-03-22
Eli Lilly Gets FDA Breakthrough Status for Alopecia Drug
2020-03-17
Thermo Fisher’s Coronavirus Detection Kit Gets FDA Emergency Authorization
2020-03-14
Janssen Bags FDA Breakthrough Therapy Designation for Lung Cancer Drug
2020-03-12
Boehringer Ingelheim’s Ofev Becomes First FDA Approved Treatment for Progressive Interstitial Lung Diseases
2020-03-11
Investigational Gene Therapy for Cystinosis Obtains FDA’s Orphan Drug Designation
2020-03-10
Spotlight: Shionogi’s Big Bet on Tetra Therapeutics
2020-03-07
GSK’s PARP Inhibitor, Zejula Gets Foot in the Door in EU to rival Rubraca and Lynparza
2020-03-06
GSK’s Trelegy Ellipta, an Advanced Treatment for Asthma & COPD Submitted for EU Approval
2020-03-05
Kainos Medicine’s New HIV Drug Kicks Off Phase III Trial in China
2020-03-05
1 43 44 45 46 47 50
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top